173 filings
Page 3 of 9
8-K
tmniy4g2 mk3j
23 Jun 22
Timber Pharmaceuticals Announces First Patients Enrolled in Phase 3 ASCEND Clinical Trial Evaluating TMB-001 in Congenital Ichthyosis
8:15am
8-K
akcm8tu15sjjkj
10 Jun 22
Regulation FD Disclosure
4:05pm
8-K
5h1zsiyi0lp5rfh10e
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
uo3vv6d20vddtayz5v
31 May 22
Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis
8:18am
8-K
bxhzzp3r18a9aomkv
12 May 22
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2022 Financial Results
4:32pm
8-K
d3lmgb7poyqlu
28 Apr 22
Timber Pharmaceuticals Announces Fast Track Designation Granted by FDA for TMB-001 in Severe Subtypes of Congenital Ichthyosis
8:20am
8-K
avl2k5s6
25 Apr 22
Other Events
5:16pm
8-K
z81nlt
11 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
6ohh4 5mua516hpze5
31 Mar 22
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results
6:20pm
8-K
tuxni12l sd12v1fu
25 Mar 22
Timber Pharmaceuticals Announces Late-Breaking Presentation at the American Academy of Dermatology 2022 Annual Meeting
4:05pm
8-K
ji1 caqjr1m
3 Feb 22
Timber Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis
8:15am
8-K
7de6hia02ut3djli09
18 Jan 22
Departure of Directors or Certain Officers
4:04pm
8-K
8mneqjk0
8 Dec 21
Regulation FD Disclosure
9:04am
8-K
ckdap25tpjjd7796p0h
22 Nov 21
Regulation FD Disclosure
9:15am
8-K
v09if4nt ift
15 Nov 21
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2021 Financial Results
12:00am
8-K
9sxqs nm2hc
4 Nov 21
Timber Pharmaceuticals Announces Proposed Public Offering
4:23pm
8-K
u351fupr 3r6on
7 Oct 21
Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis
8:59am
8-K
fe3 9vwkc0
29 Sep 21
Departure of Directors or Certain Officers
8:00am
8-K
53mbl yc4seb3djoh
16 Sep 21
Departure of Directors or Certain Officers
4:11pm
8-K
5ktjei l53rnurj
13 Sep 21
Regulation FD Disclosure
12:00am